Dyadic International (DYAI) EBIT Margin (QoQ) (2018 - 2026)
Dyadic International (DYAI) EBIT Margin (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.89 Bn | 131.04 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.05 Bn | 78.06 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.38 Bn | 1.37 Bn |
| 4 | Moderna | 55.46 Bn | 50.32 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.30 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - |
| 10 | Dyadic International | 19.89 Mn | 19.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26,679.00 |
| Dec 31, 2025 | 26,085.00 |
| Sep 30, 2025 | 1,355.00 |
| Jun 30, 2025 | 32,992.00 |
| Mar 31, 2025 | -32,160.00 |
| Dec 31, 2024 | -17,684.00 |
| Sep 30, 2024 | 51,896.00 |
| Jun 30, 2024 | 10,591.00 |
| Mar 31, 2024 | -31,933.00 |
| Dec 31, 2023 | 11,732.00 |
| Sep 30, 2023 | -15,962.00 |
| Jun 30, 2023 | -6,394.00 |
| Mar 31, 2023 | 9,148.00 |
| Dec 31, 2022 | -8,927.00 |
| Sep 30, 2022 | 29,198.00 |
| Jun 30, 2022 | -8,056.00 |
| Mar 31, 2022 | 92,238.00 |
| Dec 31, 2021 | -86,595.00 |
| Sep 30, 2021 | -6,704.00 |
| Jun 30, 2021 | 30,839.00 |